Cerebral Small Vessel Diseases
Pathological processes or diseases where cerebral MICROVESSELS show abnormalities. They are often associated with aging, hypertension and risk factors for lacunar infarcts (see LACUNAR INFARCTION); LEUKOARAIOSIS; and CEREBRAL HEMORRHAGE.
Subtype terms (6)
More specific conditions that are subtypes of Cerebral Small Vessel Diseases in the MeSH hierarchy.
- CADASIL
9 drugs (6 approved, 3 experimental)
- Cerebral Amyloid Angiopathy, Familial
- Fabry Disease
30 drugs (16 approved, 14 experimental)
- MELAS Syndrome
13 drugs (5 approved, 8 experimental)
- Microscopic Polyangiitis
19 drugs (14 approved, 5 experimental)
- Stroke, Lacunar
8 drugs (6 approved, 2 experimental)
Drugs by status
Phase 4 trials (10)
Phase 3 trials (7)
Phase 2 trials (4)
Other trials (5)
Organizations
Organization Involved with Phase 4 Indications (12)
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Other Experimental Indications (2)